Horton et al., “Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis,” Current Opinion in Lipidology 10:143-150 (1999). |
Kovanen et al., “Regulation of the low density lipoprotein (B/E) receptor,” Advances in Vascular Biology 5:165-185 (1999). |
Aguilar-Salinas et al., “Metabolic modes of action of the statins in the hyperlipoproteinemias,” Atherosclerosis 141:203-207 (1998). |
Chan et al., “Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet,” J. Nutr. 129(6):1094-1101 (Jun. 1999). |
Draijer et al., “HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice,” Biochemical Pharmacology 63:1755-1761 (2002). |
Grand-Perret et al., “SCAP ligands are potent new lipid-lowering drugs,” Nature Medicine 7(12):1332-1338 (Dec. 2001). |
Hoffmann et al., “Cholesterol lowering action of HOE 402 in the normolipidemic and hypercholesterolemic Golden Syrian hamster,” Biochimica et Biophysica Acta 1299:95-102 (1996). |
Korn et al., “Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N),” J. Clin. Invest. 102(12):2050-2060 (Dec. 1998). |
Lange et al., “Four cholesterol-sensing proteins,” Curr. Opin. Struct. Biol. 8(4):435-439 (Aug. 1998). |
Liu et al., “Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver Cells,” Cell Growth & Differentiation 5:1333-1338 (Dec. 1994). |
Liu et al., “Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M,” Journal of Lipid Research 38:2035-2048 (1997). |
Meier, “Regulation of cholesterol synthesis: of SCAP, SREBP, CBP and more,” Eur. J. Endocrinol 136(3):271-272 (Mar. 1997). |
Osbourne, “Cholesterol homeostasis: Clipping out a slippery regulator,” Current Biology 7:R172-R174 (1997). |
Thompson et al., “Novel lipid-regulating drugs,” Expert Opin. Investig. Drugs 9(11):2619-2628 (2000). |
Wang et al., “Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter,” The Journal of Biological Chemistry 268(19):14497-14504 (Jul. 1993). |
Nohturfft Axel et al: “Sterols regulate processing of carbohydrate chains of wild-type SREBP cleavage-activating protein (SCAP), but not sterol-resistant mutants Y298C or D44N”, Proceedings of the National Academy of Sciences of the United States, vol. 95, No. 22, Oct. 27, 1998, pp. 12848-12853. |
Nohturfft Axel et al: “Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain”, Journal of Biological Chemistry, vol. 273, No. 27, Jul. 3, 1998, pp. 17243-17250. |
Fajas Lluis et al: “Regulation of Peroxisome Proliferator-Activated Receptor y Expression by Adipocyte Differentiation and Determination Factor 1/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism”, Molecular adn Cellular Biology, 1999, vol. 19, No. 8, pp. 5495-5503. |
A. Simon et al., Circulation, vol. 96, 1997, pp. 2449-2452. |
A.S. Brown et al., J. Am. Coll. Cardiol., vol. 32, 1998, pp. 665-672. |
Cell, vol. 89, 1997, pp. 331-340. |
M.R. Briggs et al., J. Biol. Chem., vol. 268, 1993, pp. 14490-14496. |
C. Yokoyama et al., Cell, vol. 75, 1993, pp. 187-197. |
X. Hua et al., Proc. Natil. Acad. Sci., vol. 90, 1993, pp. 11603-11607. |
J. Sakai et al., Mol. Cell, vol. 2, 1998, pp. 505-514. |
R.B. Rawson et al., Mol. Cell, vol. 1, 1997, pp. 47-57. |
J. Sakai et al., Cell, Vol. 85, 1996, pp. 1037-1046. |
J. Sakai et al., J. Biol. Chem., vol. 272, 1997, pp. 20213-20221. |
X. Hua et al., Cell, vol. 87, 1996, pp. 415-426. |
N.B. Javitt, Faseb, vol. 9, 1995, p. 1378-1381. |
M.S. Brown and J.L. Goldstein, J. Biol. Chem., vol. 249, 1974, pp. 7306-7314. |
A. Nohthufft et al., Proc. Natl. Acad. Sci., vol. 93, 1996, pp. 13709-13714. |